Separation and characterization of a novel isoenzyme of cyclic nucleotide phosphodiesterase from rat cerebrum.
Br J Pharmacol
; 111(2): 389-90, 1994 Feb.
Article
in En
| MEDLINE
| ID: mdl-8004382
Anion-exchange chromatography on a Mono-Q column of the supernatant fraction, after ultracentrifugation, from a homogenate of rat cerebrum, prepared under isotonic conditions in the presence of protease inhibitors, yielded a novel isoenzyme of cyclic nucleotide phosphodiesterase (PDE) with properties unlike those of known PDEs. The isoenzyme was insensitive to stimulation by Ca2+/calmodulin and cyclic GMP, and it hydrolyzed both cyclic AMP and cyclic GMP with KM values of 0.109 +/- 0.008 microM and 1.78 +/- 0.04 microM, respectively. The ratio of Vmax of hydrolysis of cyclic GMP to that of cyclic AMP was 1.90 +/- 0.07. Nicardipine (PDE I inhibitor), SK&F 94120 (PDE III inhibitor), rolipram (PDE IV inhibitor) and zaprinast (PDE V inhibitor) had very weak inhibitory effects on the PDE activity of the isoenzyme. These results suggest that the isoenzyme is a novel and previously unreported species of PDE, which we tentatively designate PDE VIII.
Full text:
1
Database:
MEDLINE
Main subject:
Brain
/
3',5'-Cyclic-AMP Phosphodiesterases
/
Isoenzymes
Limits:
Animals
Language:
En
Journal:
Br J Pharmacol
Year:
1994
Type:
Article
Affiliation country:
Japan